Allied Healthcare (AHPI) 0.55 $AHPI
New York Appellate Court Rules Against Allied Healthcare Products in Stuyvesant Falls Power Covenant Lawsuit
PR Newswire - Mon Apr 04, 12:04PM CDT
On March 31, 2016, the New York Supreme Court, Appellate Division, ruled against Allied Healthcare Products, Inc. (NASDAQ: AHPI) ("Allied"
in ongoing litigation regarding covenants which Allied asserts entitle it to free electrical power at its Stuyvesant Falls production facility. In doing so, the New York Supreme Court granted summary judgment to Allied's opponents and reversed an earlier trial court decision which had ruled in favor of Allied.
AHPI: 0.55 (+0.02)
Global Respiratory Care Equipment and Supply Industry
PR Newswire - Wed Jan 27, 6:27PM CST
This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousand by the following Product Segments: Spirometers, Other Pulmonary Function Testing (PFT) Equipment, Sleep Apnea Diagnostic Devices, Ventilators, Humidifiers, Nebulizers, PAP (positive airway pressure) Devices, Oxygen Equipment, Manual Resuscitators, and Masks, Circuits & Disposables. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, The Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 158 companies including many key and niche players such as -
AHPI: 0.55 (+0.02)
Global Respiratory Care Equipment & Supplies Strategic Business Report - Analysis, Technologies & Forecasts Report - Key Vendors: AirSep Corporation, CareFusion Corporation & Covidien Ltd.
M2 - Fri Jan 15, 5:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/f79s2z/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousand by the following Product Segments: Spirometers, Other Pulmonary Function Testing (PFT) Equipment, Sleep Apnea Diagnostic Devices, Ventilators, Humidifiers, Nebulizers, PAP (positive airway pressure) Devices, Oxygen Equipment, Manual Resuscitators, and Masks, Circuits & Disposables. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Total Companies Profiled: 158 (including Divisions/Subsidiaries - 174): - The United States (84) - Canada (4) - Japan (9) - Europe (55) - France (2) - Germany (21) - The United Kingdom (9) - Italy (6) - Spain (1) - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (16) - Latin America (1) - Middle East (5) Companies Mentioned: - AirSep Corporation - Allied Healthcare Products, Inc. - CareFusion Corporation - Compumedics Limited - Covidien Ltd. Report Structure: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW 2. COMPETITION IN THE RESPIRATORY CARE MARKET 3. MARKET TRENDS BY PRODUCT SEGMENT 4. HOME HEALTHCARE MARKET - A BROAD SPECTRUM 5. PRODUCT OVERVIEW 6. RESPIRATORY THERAPY EQUIPMENT - A REVIEW 7. PAP DEVICES - THE LARGEST MARKET SEGMENT IN RESPIRATORY CARE 8. VENTILATORS FOR RESPIRATORY CARE 9. REVIEW OF SELECT DISEASE CONDITIONS REQUIRING RESPIRATORY CARE 10. PRODUCT INTRODUCTIONS, INNOVATIONS & APPROVALS 11. RECENT INDUSTRY ACTIVITY 12. FOCUS ON SELECT GLOBAL PLAYERS 13. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. THE MIDDLE EAST & AFRICA 7. LATIN AMERICA IV. COMPETITIVE LANDSCAPE For more information visit http://www.researchandmarkets.com/research/f7...atory_care
COV: 106.71 (-1.36), AHPI: 0.55 (+0.02)
Global Respiratory Care Equipment and Supply Industry - Reportlinker Review
PR Newswire - Tue Oct 20, 11:43AM CDT
This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousand by the following Product Segments: Spirometers, Other Pulmonary Function Testing (PFT) Equipment, Sleep Apnea Diagnostic Devices, Ventilators, Humidifiers, Nebulizers, PAP (positive airway pressure) Devices, Oxygen Equipment, Manual Resuscitators, and Masks, Circuits & Disposables. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, The Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 158 companies including many key and niche players such as -
AHPI: 0.55 (+0.02)
Respiratory Care Equipment and Supplies 2014-2020 - Global Strategic Business Report 2015
M2 - Thu Oct 15, 3:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qgh36t/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, The Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousand by the following Product Segments: Spirometers, Other Pulmonary Function Testing (PFT) Equipment, Sleep Apnea Diagnostic Devices, Ventilators, Humidifiers, Nebulizers, PAP (positive airway pressure) Devices, Oxygen Equipment, Manual Resuscitators, and Masks, Circuits & Disposables. The report profiles 158 companies including many key and niche players such as - Allied Healthcare Products, Inc. (USA) - Bio-Med Devices, Inc. (USA) - CareFusion Corp. (USA) - CAIRE, Inc. (USA) - Compumedics Ltd. (Australia) - Dr?ger Medical AG & Co. KGaA (Germany) - DeVilbiss Healthcare LLC (USA) - Fisher & Paykel Healthcare Corp. Limited (New Zealand) - GE Healthcare (UK) - Getinge Group (Sweden) - MAQUET GmbH & Co. KG (Germany) - Hamilton Medical AG (Switzerland) - Invacare Corporation (USA) - Itamar Medical Ltd. (Israel) - Medtronic PLC (Ireland) - nSpire Health, Inc. (USA) - PARI Medical Holding GmbH (Germany) - Philips Healthcare (The Netherlands) - ResMed (USA) - VORTRAN Medical Technology (USA) - Weinmann Ger?te f?r Medizin GmbH CCo. KG (Germany) Key Topics Covered: 1. Industry Overview 2. Competition In The Respiratory Care Market 3. Market Trends By Product Segment 4. Home Healthcare Market - A Broad Spectrum 5. Product Overview 6. Respiratory Therapy Equipment - A Review 7. Pap Devices - The Largest Market Segment In Respiratory Care 8. Ventilators For Respiratory Care 9. Review Of Select Disease Conditions Requiring Respiratory Care 10. Product Introductions, Innovations & Approvals 11. Recent Industry Activity 12. Focus On Select Global Players 13. Global Market Perspective Total Companies Profiled: 158 (including Divisions/Subsidiaries - 174) - The United States (84) - Canada (4) - Japan (9) - Europe (55) - - France (2) - - Germany (21) - - The United Kingdom (9) - - Italy (6) - - Spain (1) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (16) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/qg...atory_care
MDT: 84.22 (-1.55), IVC: 11.54 (-0.62), AHPI: 0.55 (+0.02)
COPD and Asthma Devices Market is Expected to Reach $34.3 Billion, Global, by 2020
M2 - Wed Jun 10, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m9vm99/global_copd_and) has announced the addition of the "Global COPD and Asthma Devices Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Analysis, Segmentation and Forecast, 2013 - 2020" report to their offering. The pulmonary drug delivery system includes devices such as inhalers and nebulizers - that are types of COPD and Asthma devices. Owing to all of the afore-mentioned factors the global COPD and Asthma devices' market was valued at $25.3 billion in 2013. The global COPD and Asthma devices market is segmented based on product/device types - inhalers and nebulizers. There are three types of inhalers, namely Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs) and Soft Mist Inhalers (SMIs). Currently, MDIs constitute to the largest market share of about 46% of the global COPD and Asthma devices market. The DPIs is the fastest growing segment owing to the increase in the adoption rate of DPIs (as compared to other types of inhalers). The ability of DPIs to deliver small and large-sized drug molecules, as well as specialty engineered molecules render it to be the most preferred inhaler by the customers (doctors);therefore, contributing largely to the growth of the DPIs segment market. The other product type segment, i.e. the Nebulizers, is the device wherein the liquid formulation of drug is dispensed with the help of compressed air. There are various types of nebulizers developed and supplied such as Compressor Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers. The nebulizers hold a largest market share in the Home Healthcare application, as the product design of nebulizers offers benefits to debilitated patients, geriatrics and children. Geographically, the COPD and Asthma devices market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America holds the largest market share followed by Europe. Companies Mentioned: - 3M Health Care - Allied Healthcare Products Inc. - AstraZeneca Plc - Baxter International - GF Healthcare Products - GlaxoSmithKline Plc - Lincare Holdings Inc. - Merck & Co. - Novartis AG - Philips Healthcare - Smith Medicals - Sunovion Pharmaceuticals Inc. For more information visit http://www.researchandmarkets.com/research/m9...l_copd_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BAX: 44.24 (-1.72), MRK: 56.40 (-1.28), AZN: 28.18 (-1.11), AHPI: 0.55 (+0.02), GSK: 41.21 (-1.35), NVS: 78.75 (-1.92)
Nasdaq stocks posting largest volume increases
AP - Tue Apr 14, 4:58PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
NSYS: 3.79 (+0.14), DOVR: 8.43 (+0.03), EBIO: 2.17 (-0.12), ORMP: 8.17 (+0.02), AHPI: 0.55 (+0.02), SYRX: 0.48 (-0.03), INPH: 0.04 (unch), NTIC: 10.86 (-0.14)
How it All Plays Out: Research Reports on Align Technology, Alimera, Alkermes, Alliance HealthCare Services, and Allied Healthcare Products
PR Newswire - Tue Feb 03, 7:50AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Align Technology (NASDAQ: ALGN), Alimera (NASDAQ: ALIM), Alkermes (NASDAQ: ALKS), Alliance HealthCare Services, (NASDAQ: AIQ), and Allied Healthcare Products (NASDAQ: AHPI). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
ALGN: 79.69 (-2.13), ALIM: 1.38 (-0.11), AHPI: 0.55 (+0.02), ALKS: 43.25 (-0.50), AIQ: 6.06 (-0.13)
Global COPD and Asthma Devices Market (Product Types and Geography) 2013 - 2020
M2 - Wed Dec 03, 8:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/8nv92w/global_copd_and) has announced the addition of the "Global COPD and Asthma Devices Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Analysis, Segmentation and Forecast, 2013 - 2020" report to their offering. The global COPD and asthma devices market would reach $34.3 billionby 2020, registering a CAGR of 4.5% during 2014 - 2020. Considering the growth and market size, Dry Powder Inhalers (DPIs) will be the most lucrative market segment of the COPD and Asthma devices (inhalers) market by 2020. Metered Dose Inhalers (MDIs) are the largest revenue generating segment currently and would maintain the stand till 2020. The need for urgency in medication and portability of the drug delivery devices will drive the growth for COPD and Asthma devices. Despite notable advantages of the COPD and Asthma devices, some factors such as environmental concerns are likely to impede the growth of COPD and Asthma devices market. It is observed that the inhalers, particularly the MDIs, release environmentally-hazardous gases, namely chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA), which is negatively impacting growth of the MDIs segment. Consumption pattern will shift to better alternatives, namely the DPIs. The Soft Mist Inhalers (SMIs), which are another type of inhalers, deliver metered dosage of medication as a soft mist. Such form of drug delivery is -65% to 80% more efficacious than its peers and will eventually display higher growth as compared to its peers. Nebulizers, electric or battery powered machines that dispense medication as a fine mist, are ideal for home healthcare set-up for debilitated patients, geriatrics and children. Nebulizers segment thus holds about 13% of the global COPD and Asthma devices market; however, the nebulizers market is forecast to have diminishing growth through 2020 as nebulizers are rendered ineffectual, as POC or portable COPD and Asthma devices due to its larger set up. Key findings of the study: - Drug powder inhalers (DPIs) segment will grow at a CAGR of 5.3% during the forecast period, fastest among all - North American market would be one of the most lucrative markets, in terms of growth - European market for COPD and asthma devices would reach $10 billion by 2020, with the CAGR of 4.8% - Within the nebulizers segment markets, compressor nebulizers would be most lucrative, growing at 7% CAGR during the forecast period and compressor nebulizers would garner 81.5% market share by 2020 Specific focus to achieve product differentiation and thus gain competitive advantage drives the development of new product variants of COPD and Asthma devices. In accordance to the afore-mentioned trend, the market has witnessed steady stream of product launch. Key product manufacturing companies profiled in the report include GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc., Sunovion Pharmaceuticals Inc., GF Healthcare Products, Smith Medicals, Lincare Holdings Inc. and Baxter International. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL COPD AND ASTHMA DEVICES MARKET BY PRODUCT TYPE, 2013-2020, $MILLION CHAPTER 5 GLOBAL COPD AND ASTHMA DEVICES MARKET BY GEOGRAPHY, 2013-2020, $MILLION CHAPTER 6 COMPANY PROFILES - 3M Health Care - Allied Healthcare Products Inc. - AstraZeneca Plc - Baxter International - GF Healthcare Products - GlaxoSmithKline Plc - Lincare Holdings Inc. - Merck & Co. - Novartis AG - Philips Healthcare - Smith Medicals - Sunovion Pharmaceuticals Inc. For more information visit http://www.researchandmarkets.com/research/8n...l_copd_and
BAX: 44.24 (-1.72), MRK: 56.40 (-1.28), AZN: 28.18 (-1.11), AHPI: 0.55 (+0.02), GSK: 41.21 (-1.35), NVS: 78.75 (-1.92)
OTC Daily Alert Stock Watch - Allied Healthcare Products, Inc (NASDAQ: AHPI)
WorldStockWire - Mon Nov 10, 12:30PM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
AHPI: 0.55 (+0.02)
Respiratory Care Equipment and Supplies - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9qjvss/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousands by the following Product Segments: - Spirometers - Other Pulmonary Function Testing (PFT) Equipment - Sleep Apnea Diagnostic Devices - Ventilators - Humidifiers - Nebulizers - PAP (positive airway pressure) - Devices - Oxygen Equipment - Manual Resuscitators - Masks - Circuits & Disposables The report profiles 148 companies including many key and niche players such as: - AirSep Corporation - Allied Healthcare Products, Inc. - CareFusion Corporation - Compumedics Limited - Covidien Ltd. - Dr?ger Medical AG & Co. KGaA - DeVilbiss Healthcare - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - Getinge Group - MAQUET GmbH & Co. KG - Hamilton Medical AG - Invacare Corporation - Itamar Medical Ltd. - nSpire Health, Inc. - Philips Healthcare - ResMed - VORTRAN Medical Technology - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Respiratory Care Industry Classification 3. Competition In The Respiratory Care Market 4. Market Trends And Growth Drivers By Segment 5. Respiratory Diagnostics Equipment - A Review 6. Respiratory Therapy Equipment - A Review 7. Review Of Select Disease Conditions Requiring Respiratory Care 8. Pap Devices - The Largest Market Segment In Respiratory Care 9. Home Healthcare Market - A Broad Spectrum 10. Ventilators For Respiratory Care 11. Product Introductions/Innovations 12. Recent Industry Activity 13. Focus On Select Global Players 14. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 148 (including Divisions/Subsidiaries - 174) - The United States (78) - Canada (4) - Japan (9) - Europe (62) - - France (4) - - Germany (24) - - The United Kingdom (9) - - Italy (7) - - Spain (2) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (15) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/9q...atory_care
IVC: 11.54 (-0.62), COV: 106.71 (-1.36), AHPI: 0.55 (+0.02)
Market Maker Surveillance Report. AHPI, APT, LAKE, IBIO, CDXS, MPO, Losing Stocks With Lowest Price Friction For Tuesday, October 14th 2014
M2 - Wed Oct 15, 3:11AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4904 companies with "abnormal" market making, 2632 companies with positive Friction Factors and 2319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Allied Healthcare Products Inc (NASDAQ:AHPI), Alpha Pro Tech Ltd (NYSE:APT), Lakeland Industries Inc (NASDAQ:LAKE), Ibio Inc (NYSE:IBIO), Codexis Inc (NASDAQ:CDXS), Midstates Petroleum Company Inc (NYSE:MPO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
APT: 2.14 (+0.02), AHPI: 0.55 (+0.02), MPO: 0.71 (unch), CDXS: 4.22 (+0.01), IBIO: 0.65 (+0.02), LAKE: 8.50 (-0.22)
New York Appellate Court Rules Against Allied Healthcare Products in Stuyvesant Falls Power Covenant Lawsuit
PR Newswire - Mon Apr 04, 12:04PM CDT
On March 31, 2016, the New York Supreme Court, Appellate Division, ruled against Allied Healthcare Products, Inc. (NASDAQ: AHPI) ("Allied"
in ongoing litigation regarding covenants which Allied asserts entitle it to free electrical power at its Stuyvesant Falls production facility. In doing so, the New York Supreme Court granted summary judgment to Allied's opponents and reversed an earlier trial court decision which had ruled in favor of Allied. AHPI: 0.55 (+0.02)
Global Respiratory Care Equipment and Supply Industry
PR Newswire - Wed Jan 27, 6:27PM CST
This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousand by the following Product Segments: Spirometers, Other Pulmonary Function Testing (PFT) Equipment, Sleep Apnea Diagnostic Devices, Ventilators, Humidifiers, Nebulizers, PAP (positive airway pressure) Devices, Oxygen Equipment, Manual Resuscitators, and Masks, Circuits & Disposables. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, The Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 158 companies including many key and niche players such as -
AHPI: 0.55 (+0.02)
Global Respiratory Care Equipment & Supplies Strategic Business Report - Analysis, Technologies & Forecasts Report - Key Vendors: AirSep Corporation, CareFusion Corporation & Covidien Ltd.
M2 - Fri Jan 15, 5:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/f79s2z/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousand by the following Product Segments: Spirometers, Other Pulmonary Function Testing (PFT) Equipment, Sleep Apnea Diagnostic Devices, Ventilators, Humidifiers, Nebulizers, PAP (positive airway pressure) Devices, Oxygen Equipment, Manual Resuscitators, and Masks, Circuits & Disposables. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Total Companies Profiled: 158 (including Divisions/Subsidiaries - 174): - The United States (84) - Canada (4) - Japan (9) - Europe (55) - France (2) - Germany (21) - The United Kingdom (9) - Italy (6) - Spain (1) - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (16) - Latin America (1) - Middle East (5) Companies Mentioned: - AirSep Corporation - Allied Healthcare Products, Inc. - CareFusion Corporation - Compumedics Limited - Covidien Ltd. Report Structure: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW 2. COMPETITION IN THE RESPIRATORY CARE MARKET 3. MARKET TRENDS BY PRODUCT SEGMENT 4. HOME HEALTHCARE MARKET - A BROAD SPECTRUM 5. PRODUCT OVERVIEW 6. RESPIRATORY THERAPY EQUIPMENT - A REVIEW 7. PAP DEVICES - THE LARGEST MARKET SEGMENT IN RESPIRATORY CARE 8. VENTILATORS FOR RESPIRATORY CARE 9. REVIEW OF SELECT DISEASE CONDITIONS REQUIRING RESPIRATORY CARE 10. PRODUCT INTRODUCTIONS, INNOVATIONS & APPROVALS 11. RECENT INDUSTRY ACTIVITY 12. FOCUS ON SELECT GLOBAL PLAYERS 13. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. THE MIDDLE EAST & AFRICA 7. LATIN AMERICA IV. COMPETITIVE LANDSCAPE For more information visit http://www.researchandmarkets.com/research/f7...atory_care
COV: 106.71 (-1.36), AHPI: 0.55 (+0.02)
Global Respiratory Care Equipment and Supply Industry - Reportlinker Review
PR Newswire - Tue Oct 20, 11:43AM CDT
This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousand by the following Product Segments: Spirometers, Other Pulmonary Function Testing (PFT) Equipment, Sleep Apnea Diagnostic Devices, Ventilators, Humidifiers, Nebulizers, PAP (positive airway pressure) Devices, Oxygen Equipment, Manual Resuscitators, and Masks, Circuits & Disposables. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, The Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 158 companies including many key and niche players such as -
AHPI: 0.55 (+0.02)
Respiratory Care Equipment and Supplies 2014-2020 - Global Strategic Business Report 2015
M2 - Thu Oct 15, 3:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qgh36t/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, The Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousand by the following Product Segments: Spirometers, Other Pulmonary Function Testing (PFT) Equipment, Sleep Apnea Diagnostic Devices, Ventilators, Humidifiers, Nebulizers, PAP (positive airway pressure) Devices, Oxygen Equipment, Manual Resuscitators, and Masks, Circuits & Disposables. The report profiles 158 companies including many key and niche players such as - Allied Healthcare Products, Inc. (USA) - Bio-Med Devices, Inc. (USA) - CareFusion Corp. (USA) - CAIRE, Inc. (USA) - Compumedics Ltd. (Australia) - Dr?ger Medical AG & Co. KGaA (Germany) - DeVilbiss Healthcare LLC (USA) - Fisher & Paykel Healthcare Corp. Limited (New Zealand) - GE Healthcare (UK) - Getinge Group (Sweden) - MAQUET GmbH & Co. KG (Germany) - Hamilton Medical AG (Switzerland) - Invacare Corporation (USA) - Itamar Medical Ltd. (Israel) - Medtronic PLC (Ireland) - nSpire Health, Inc. (USA) - PARI Medical Holding GmbH (Germany) - Philips Healthcare (The Netherlands) - ResMed (USA) - VORTRAN Medical Technology (USA) - Weinmann Ger?te f?r Medizin GmbH CCo. KG (Germany) Key Topics Covered: 1. Industry Overview 2. Competition In The Respiratory Care Market 3. Market Trends By Product Segment 4. Home Healthcare Market - A Broad Spectrum 5. Product Overview 6. Respiratory Therapy Equipment - A Review 7. Pap Devices - The Largest Market Segment In Respiratory Care 8. Ventilators For Respiratory Care 9. Review Of Select Disease Conditions Requiring Respiratory Care 10. Product Introductions, Innovations & Approvals 11. Recent Industry Activity 12. Focus On Select Global Players 13. Global Market Perspective Total Companies Profiled: 158 (including Divisions/Subsidiaries - 174) - The United States (84) - Canada (4) - Japan (9) - Europe (55) - - France (2) - - Germany (21) - - The United Kingdom (9) - - Italy (6) - - Spain (1) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (16) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/qg...atory_care
MDT: 84.22 (-1.55), IVC: 11.54 (-0.62), AHPI: 0.55 (+0.02)
COPD and Asthma Devices Market is Expected to Reach $34.3 Billion, Global, by 2020
M2 - Wed Jun 10, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m9vm99/global_copd_and) has announced the addition of the "Global COPD and Asthma Devices Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Analysis, Segmentation and Forecast, 2013 - 2020" report to their offering. The pulmonary drug delivery system includes devices such as inhalers and nebulizers - that are types of COPD and Asthma devices. Owing to all of the afore-mentioned factors the global COPD and Asthma devices' market was valued at $25.3 billion in 2013. The global COPD and Asthma devices market is segmented based on product/device types - inhalers and nebulizers. There are three types of inhalers, namely Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs) and Soft Mist Inhalers (SMIs). Currently, MDIs constitute to the largest market share of about 46% of the global COPD and Asthma devices market. The DPIs is the fastest growing segment owing to the increase in the adoption rate of DPIs (as compared to other types of inhalers). The ability of DPIs to deliver small and large-sized drug molecules, as well as specialty engineered molecules render it to be the most preferred inhaler by the customers (doctors);therefore, contributing largely to the growth of the DPIs segment market. The other product type segment, i.e. the Nebulizers, is the device wherein the liquid formulation of drug is dispensed with the help of compressed air. There are various types of nebulizers developed and supplied such as Compressor Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers. The nebulizers hold a largest market share in the Home Healthcare application, as the product design of nebulizers offers benefits to debilitated patients, geriatrics and children. Geographically, the COPD and Asthma devices market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America holds the largest market share followed by Europe. Companies Mentioned: - 3M Health Care - Allied Healthcare Products Inc. - AstraZeneca Plc - Baxter International - GF Healthcare Products - GlaxoSmithKline Plc - Lincare Holdings Inc. - Merck & Co. - Novartis AG - Philips Healthcare - Smith Medicals - Sunovion Pharmaceuticals Inc. For more information visit http://www.researchandmarkets.com/research/m9...l_copd_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BAX: 44.24 (-1.72), MRK: 56.40 (-1.28), AZN: 28.18 (-1.11), AHPI: 0.55 (+0.02), GSK: 41.21 (-1.35), NVS: 78.75 (-1.92)
Nasdaq stocks posting largest volume increases
AP - Tue Apr 14, 4:58PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
NSYS: 3.79 (+0.14), DOVR: 8.43 (+0.03), EBIO: 2.17 (-0.12), ORMP: 8.17 (+0.02), AHPI: 0.55 (+0.02), SYRX: 0.48 (-0.03), INPH: 0.04 (unch), NTIC: 10.86 (-0.14)
How it All Plays Out: Research Reports on Align Technology, Alimera, Alkermes, Alliance HealthCare Services, and Allied Healthcare Products
PR Newswire - Tue Feb 03, 7:50AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Align Technology (NASDAQ: ALGN), Alimera (NASDAQ: ALIM), Alkermes (NASDAQ: ALKS), Alliance HealthCare Services, (NASDAQ: AIQ), and Allied Healthcare Products (NASDAQ: AHPI). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
ALGN: 79.69 (-2.13), ALIM: 1.38 (-0.11), AHPI: 0.55 (+0.02), ALKS: 43.25 (-0.50), AIQ: 6.06 (-0.13)
Global COPD and Asthma Devices Market (Product Types and Geography) 2013 - 2020
M2 - Wed Dec 03, 8:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/8nv92w/global_copd_and) has announced the addition of the "Global COPD and Asthma Devices Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Analysis, Segmentation and Forecast, 2013 - 2020" report to their offering. The global COPD and asthma devices market would reach $34.3 billionby 2020, registering a CAGR of 4.5% during 2014 - 2020. Considering the growth and market size, Dry Powder Inhalers (DPIs) will be the most lucrative market segment of the COPD and Asthma devices (inhalers) market by 2020. Metered Dose Inhalers (MDIs) are the largest revenue generating segment currently and would maintain the stand till 2020. The need for urgency in medication and portability of the drug delivery devices will drive the growth for COPD and Asthma devices. Despite notable advantages of the COPD and Asthma devices, some factors such as environmental concerns are likely to impede the growth of COPD and Asthma devices market. It is observed that the inhalers, particularly the MDIs, release environmentally-hazardous gases, namely chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA), which is negatively impacting growth of the MDIs segment. Consumption pattern will shift to better alternatives, namely the DPIs. The Soft Mist Inhalers (SMIs), which are another type of inhalers, deliver metered dosage of medication as a soft mist. Such form of drug delivery is -65% to 80% more efficacious than its peers and will eventually display higher growth as compared to its peers. Nebulizers, electric or battery powered machines that dispense medication as a fine mist, are ideal for home healthcare set-up for debilitated patients, geriatrics and children. Nebulizers segment thus holds about 13% of the global COPD and Asthma devices market; however, the nebulizers market is forecast to have diminishing growth through 2020 as nebulizers are rendered ineffectual, as POC or portable COPD and Asthma devices due to its larger set up. Key findings of the study: - Drug powder inhalers (DPIs) segment will grow at a CAGR of 5.3% during the forecast period, fastest among all - North American market would be one of the most lucrative markets, in terms of growth - European market for COPD and asthma devices would reach $10 billion by 2020, with the CAGR of 4.8% - Within the nebulizers segment markets, compressor nebulizers would be most lucrative, growing at 7% CAGR during the forecast period and compressor nebulizers would garner 81.5% market share by 2020 Specific focus to achieve product differentiation and thus gain competitive advantage drives the development of new product variants of COPD and Asthma devices. In accordance to the afore-mentioned trend, the market has witnessed steady stream of product launch. Key product manufacturing companies profiled in the report include GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc., Sunovion Pharmaceuticals Inc., GF Healthcare Products, Smith Medicals, Lincare Holdings Inc. and Baxter International. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL COPD AND ASTHMA DEVICES MARKET BY PRODUCT TYPE, 2013-2020, $MILLION CHAPTER 5 GLOBAL COPD AND ASTHMA DEVICES MARKET BY GEOGRAPHY, 2013-2020, $MILLION CHAPTER 6 COMPANY PROFILES - 3M Health Care - Allied Healthcare Products Inc. - AstraZeneca Plc - Baxter International - GF Healthcare Products - GlaxoSmithKline Plc - Lincare Holdings Inc. - Merck & Co. - Novartis AG - Philips Healthcare - Smith Medicals - Sunovion Pharmaceuticals Inc. For more information visit http://www.researchandmarkets.com/research/8n...l_copd_and
BAX: 44.24 (-1.72), MRK: 56.40 (-1.28), AZN: 28.18 (-1.11), AHPI: 0.55 (+0.02), GSK: 41.21 (-1.35), NVS: 78.75 (-1.92)
OTC Daily Alert Stock Watch - Allied Healthcare Products, Inc (NASDAQ: AHPI)
WorldStockWire - Mon Nov 10, 12:30PM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
AHPI: 0.55 (+0.02)
Respiratory Care Equipment and Supplies - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9qjvss/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousands by the following Product Segments: - Spirometers - Other Pulmonary Function Testing (PFT) Equipment - Sleep Apnea Diagnostic Devices - Ventilators - Humidifiers - Nebulizers - PAP (positive airway pressure) - Devices - Oxygen Equipment - Manual Resuscitators - Masks - Circuits & Disposables The report profiles 148 companies including many key and niche players such as: - AirSep Corporation - Allied Healthcare Products, Inc. - CareFusion Corporation - Compumedics Limited - Covidien Ltd. - Dr?ger Medical AG & Co. KGaA - DeVilbiss Healthcare - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - Getinge Group - MAQUET GmbH & Co. KG - Hamilton Medical AG - Invacare Corporation - Itamar Medical Ltd. - nSpire Health, Inc. - Philips Healthcare - ResMed - VORTRAN Medical Technology - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Respiratory Care Industry Classification 3. Competition In The Respiratory Care Market 4. Market Trends And Growth Drivers By Segment 5. Respiratory Diagnostics Equipment - A Review 6. Respiratory Therapy Equipment - A Review 7. Review Of Select Disease Conditions Requiring Respiratory Care 8. Pap Devices - The Largest Market Segment In Respiratory Care 9. Home Healthcare Market - A Broad Spectrum 10. Ventilators For Respiratory Care 11. Product Introductions/Innovations 12. Recent Industry Activity 13. Focus On Select Global Players 14. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 148 (including Divisions/Subsidiaries - 174) - The United States (78) - Canada (4) - Japan (9) - Europe (62) - - France (4) - - Germany (24) - - The United Kingdom (9) - - Italy (7) - - Spain (2) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (15) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/9q...atory_care
IVC: 11.54 (-0.62), COV: 106.71 (-1.36), AHPI: 0.55 (+0.02)
Market Maker Surveillance Report. AHPI, APT, LAKE, IBIO, CDXS, MPO, Losing Stocks With Lowest Price Friction For Tuesday, October 14th 2014
M2 - Wed Oct 15, 3:11AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4904 companies with "abnormal" market making, 2632 companies with positive Friction Factors and 2319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Allied Healthcare Products Inc (NASDAQ:AHPI), Alpha Pro Tech Ltd (NYSE:APT), Lakeland Industries Inc (NASDAQ:LAKE), Ibio Inc (NYSE:IBIO), Codexis Inc (NASDAQ:CDXS), Midstates Petroleum Company Inc (NYSE:MPO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
APT: 2.14 (+0.02), AHPI: 0.55 (+0.02), MPO: 0.71 (unch), CDXS: 4.22 (+0.01), IBIO: 0.65 (+0.02), LAKE: 8.50 (-0.22)
